Get comprehensive analysis of Bristol-Myers Squibb Company (BMY) stock with our professional-grade research platform. Our analysis combines DCF valuation models with AI-powered predictions to give you the complete picture.
Bristol-Myers Squibb Company is a Healthcare company with a market capitalization of $136.49 billion. Currently trading at $66.82, the stock is down 1.87% today.
Bristol-Myers Squibb Company (BMY) represents a significant investment opportunity in the Healthcare sector. Understanding the company's financial health, valuation metrics, and growth prospects is essential for making informed investment decisions.
Our analysis provides institutional-grade research typically reserved for professional investors, now available for free. We update BMY data daily to ensure you have the most current information for your investment decisions.